CNB Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.11M | Buy |
14,318
+15
| +0.1% | +$3.33K | 1.31% | 18 |
|
|
2025
Q4 | $3.27M | Sell |
14,303
-102
| -0.7% | -$23.2K | 1.34% | 16 |
|
|
2025
Q3 | $3.34M | Buy |
14,405
+368
| +3% | +$74.9K | 1.39% | 15 |
|
|
2025
Q2 | $2.61M | Sell |
14,037
-315
| -2% | -$58.5K | 1.24% | 17 |
|
|
2025
Q1 | $3.01M | Sell |
14,352
-1,251
| -8% | -$243K | 1.52% | 13 |
|
|
2024
Q4 | $2.77M | Sell |
15,603
-414
| -3% | -$76.1K | 1.29% | 17 |
|
|
2024
Q3 | $3.16M | Sell |
16,017
-544
| -3% | -$102K | 1.46% | 11 |
|
|
2024
Q2 | $2.84M | Sell |
16,561
-2,565
| -13% | -$425K | 1.37% | 13 |
|
|
2024
Q1 | $3.48M | Sell |
19,126
-926
| -5% | -$160K | 1.7% | 9 |
|
|
2023
Q4 | $3.11M | Sell |
20,052
-948
| -5% | -$138K | 1.67% | 10 |
|
|
2023
Q3 | $3.13M | Buy |
21,000
+631
| +3% | +$92.6K | 1.84% | 10 |
|
|
2023
Q2 | $2.74M | Sell |
20,369
-535
| -3% | -$78.5K | 1.61% | 11 |
|
|
2023
Q1 | $3.33M | Buy |
20,904
+833
| +4% | +$127K | 2.03% | 6 |
|
|
2022
Q4 | $3.24M | Sell |
20,071
-635
| -3% | -$97.4K | 2.03% | 9 |
|
|
2022
Q3 | $2.78M | Buy |
20,706
+400
| +2% | +$57.4K | 1.88% | 9 |
|
|
2022
Q2 | $3.11M | Sell |
20,306
-1,602
| -7% | -$245K | 2.01% | 8 |
|
|
2022
Q1 | $3.55M | Sell |
21,908
-697
| -3% | -$101K | 1.99% | 8 |
|
|
2021
Q4 | $3.06M | Sell |
22,605
-386
| -2% | -$45.6K | 1.68% | 9 |
|
|
2021
Q3 | $2.48M | Buy |
22,991
+2,019
| +10% | +$231K | 1.49% | 10 |
|
|
2021
Q2 | $2.36M | Sell |
20,972
-176
| -0.8% | -$19.8K | 1.48% | 10 |
|
|
2021
Q1 | $2.29M | Sell |
21,148
-229
| -1% | -$24.5K | 1.58% | 9 |
|
|
2020
Q4 | $2.29M | Buy |
21,377
+2,030
| +10% | +$195K | 1.73% | 9 |
|
|
2020
Q3 | $1.7M | Sell |
19,347
-1,327
| -6% | -$125K | 1.43% | 12 |
|
|
2020
Q2 | $2.03M | Buy |
20,674
+1,425
| +7% | +$125K | 1.79% | 8 |
|
|
2020
Q1 | $1.47M | Buy |
19,249
+3,657
| +23% | +$311K | 1.58% | 12 |
|
|
2019
Q4 | $1.38M | Buy |
15,592
+992
| +7% | +$82.4K | 1.17% | 19 |
|
|
2019
Q3 | $1.11M | Buy |
14,600
+3,126
| +27% | +$214K | 1.02% | 22 |
|
|
2019
Q2 | $834K | Buy |
11,474
+1,548
| +16% | +$122K | 0.71% | 35 |
|
|
2019
Q1 | $800K | Buy |
9,926
+437
| +5% | +$35.8K | 0.41% | 43 |
|
|
2018
Q4 | $875K | Buy |
9,489
+517
| +6% | +$45.5K | 0.56% | 28 |
|
|
2018
Q3 | $849K | Sell |
8,972
-420
| -4% | -$39.8K | 0.49% | 30 |
|
|
2018
Q2 | $870K | Buy |
9,392
+80
| +0.9% | +$7.81K | 0.51% | 28 |
|
|
2018
Q1 | $882K | Sell |
9,312
-1,026
| -10% | -$113K | 0.52% | 27 |
|
|
2017
Q4 | $1M | Buy |
+10,338
| New | +$974K | 0.6% | 26 |
|
Other funds holding ABBV
VCM
VPM
CNB Bank's ABBV Position: Q1 2026 in Review
CNB Bank increased its AbbVie (ABBV) stake by 0.1% in Q1 2026, buying an estimated $3.33K and bringing the position to 14,318 shares worth $3.11M. The position accounts for 1.31% of the portfolio, ranked #18.
CNB Bank first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.55M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- CNB Bank held 14,318 shares of AbbVie worth $3.11M as of Q1 2026.
- CNB Bank bought 15 AbbVie shares in Q1 2026, an estimated $3.33K.
- AbbVie made up 1.31% of CNB Bank's portfolio in Q1 2026, its #18 holding.
- CNB Bank first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- CNB Bank's AbbVie position peaked at $3.55M in Q1 2022.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.